Tag Archives: Inflation Reduction Act (IRA)

In ‘First Major Blow to Big Pharma,’ Federal Judge Blocks Medicare Drug Price Negotiation Injunction

The judge said plaintiff the Chamber of Commerce “demonstrated neither a strong likelihood of success nor irreparable harm.”

By Olivia Rosane. Published 9-30-2023 by Common Dreams

A federal judge in Ohio on Friday blocked an attempt by corporate interests to stop Medicare’s historic negotiation of certain drug prices with pharmaceuticals.

Medicare gained the power to negotiate drug prices as part of the Inflation Reduction Act (IRA), but the several industry groups and drug makers have sued to forestall the program, arguing that it is unconstitutional, CNN explained. One of those groups was the U.S. Chamber of Commerce, which filed its lawsuit in June. The Ohio judge Friday rejected its request for a preliminary injunction to block the program before October 1, the date by which pharmaceuticals must agree to negotiate or not.

Continue reading →

With Funds Opposed by GOP, IRS to Target Ultrawealthy Tax Delinquents

“This news stands in stark contrast to the approach taken by House Republicans, who want to allow wealthy tax cheats to continue business as usual,” said U.S. Senate Finance Committee Chair Ron Wyden.

By Jessica Corbett. Published 9-8-2023 by Common Dreams

Internal Revenue Service Commissioner Daniel Werfel . Screenshot: C-SPAN

The U.S. Internal Revenue Service on Friday won praise from congressional Democrats and progressive groups for announcing “a sweeping, historic effort to restore fairness in tax compliance by shifting more attention onto high-income earners, partnerships, large corporations, and promoters abusing the nation’s tax laws.”

The IRS effort is enabled by some of the $80 billion in funding for the agency included in the Inflation Reduction Act (IRA), which President Joe Biden signed into law last year. About a quarter of that money is set to be clawed back as part of his recent deal with congressional Republicans to temporarily suspend the nation’s debt limit.

Continue reading →

Patients Push Biden HHS to Act as Pharma Firm Charges $190K for Lifesaving Prostate Cancer Drug

“HHS can clearly insist on limiting the U.S. price of Xtandi to the median price for other large high-income countries,” said advocates, “particularly since the drug has already generated more than $10 billion in sales from Medicare alone based upon these unconscionable pricing disparities.”

By Brett Wilkins Published 11-20-2022 by Common Dreams

Screenshot: GlobalGiving

“Cancer does not wait, nor should cancer patients have to wait for years for their government to act.”

That’s the message patient advocates reiterated in a Friday letter asking the Biden administration to help them secure a lifesaving prostate cancer drug that costs nearly $190,000 per year despite its development being 100% taxpayer-funded.

Last year, prostate cancer patient Eric Sawyer petitioned U.S. Health and Human Services (HHS) Secretary Xavier Becerra to grant march-in rights—under which the government can grant patent licenses to companies other than a drug’s manufacturer—for enzalutamide, which is sold under the brand name Xtandi. Continue reading →

Occupy World Writes

The Movement Continues – Globally

Tag Archives: Inflation Reduction Act (IRA)